Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens
Aims. Cardiovascular diseases are the primary cause of premature morbidity and mortality in early breast cancer patients after treatment with cardiotoxic chemotherapeutic agents. Arterial stiffness is an independent risk factor for future cardiovascular diseases and can be used as a predictive marke...
Saved in:
Main Authors: | Özlem Yersal, Ufuk Eryilmaz, Hakan Akdam, Nezih Meydan, Sabri Barutca |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2018/5352914 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation
by: Esin Oktay, et al.
Published: (2013-01-01) -
Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines
by: Vivian I. Franco, et al.
Published: (2011-01-01) -
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan
by: Alessandra Fabi, et al.
Published: (2025-01-01) -
In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment
by: Sietske B.M. Gaykema, et al.
Published: (2014-07-01) -
Anthracycline-induced arrhythmias in breast cancer therapy: A meta-analysis of single-arm trials.
by: Tao Ran, et al.
Published: (2024-01-01)